MIST
Price:
$1.46
Market Cap:
$77.77M
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans. The company was incorporated in 2003 and is headquartered in Montréal, Canada.[Read more]
Industry
Biotechnology
IPO Date
2019-05-09
Stock Exchange
NASDAQ
Ticker
MIST
According to Milestone Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.45. This represents a change of -25.82% compared to the average of -1.95 of the last 4 quarters.
The mean historical PE Ratio of Milestone Pharmaceuticals Inc. over the last ten years is -11.39. The current -1.45 PE Ratio has changed 1.17% with respect to the historical average. Over the past ten years (40 quarters), MIST's PE Ratio was at its highest in in the June 2021 quarter at 74.42. The PE Ratio was at its lowest in in the June 2018 quarter at -25.32.
Average
-11.39
Median
-4.58
Minimum
-44.95
Maximum
-1.20
Discovering the peaks and valleys of Milestone Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 63.34%
Maximum Annual PE Ratio = -1.20
Minimum Annual Increase = -70.81%
Minimum Annual PE Ratio = -44.95
Year | PE Ratio | Change |
---|---|---|
2023 | -1.20 | -59.15% |
2022 | -2.94 | -54.22% |
2021 | -6.43 | 63.34% |
2020 | -3.93 | -14.01% |
2019 | -4.58 | -70.81% |
2018 | -15.68 | -65.12% |
The current PE Ratio of Milestone Pharmaceuticals Inc. (MIST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.52
5-year avg
-3.82
10-year avg
-11.39
Milestone Pharmaceuticals Inc.’s PE Ratio is greater than DiaMedica Therapeutics Inc. (-7.71), less than Seres Therapeutics, Inc. (-0.89), less than Inhibikase Therapeutics, Inc. (-0.55), greater than Oncolytics Biotech Inc. (-3.53), greater than scPharmaceuticals Inc. (-3.28), greater than aTyr Pharma, Inc. (-2.33), less than X4 Pharmaceuticals, Inc. (7.41), less than Galera Therapeutics, Inc. (-0.14), greater than Terns Pharmaceuticals, Inc. (-6.06), greater than Day One Biopharmaceuticals, Inc. (-7.39), less than HOOKIPA Pharma Inc. (-1.22), less than Spero Therapeutics, Inc. (4.06), less than Bolt Biotherapeutics, Inc. (-0.37), greater than Coherus BioSciences, Inc. (-4.85), greater than Gracell Biotechnologies Inc. (-12.26), less than Neoleukin Therapeutics, Inc. (-0.98), greater than Monte Rosa Therapeutics, Inc. (-3.11), greater than NewAmsterdam Pharma Company N.V. (-7.25), less than Inventiva S.A. (-0.87), greater than Cullinan Oncology, Inc. (-6.96), greater than Compass Therapeutics, Inc. (-4.30),
Company | PE Ratio | Market cap |
---|---|---|
-7.71 | $172.27M | |
-0.89 | $145.36M | |
-0.55 | $10.00M | |
-3.53 | $73.75M | |
-3.28 | $255.65M | |
-2.33 | $131.12M | |
7.41 | $109.78M | |
-0.14 | $4.08M | |
-6.06 | $549.60M | |
-7.39 | $1.25B | |
-1.22 | $159.50M | |
4.06 | $71.07M | |
-0.37 | $24.78M | |
-4.85 | $142.86M | |
-12.26 | $989.87M | |
-0.98 | $8.20M | |
-3.11 | $349.21M | |
-7.25 | $1.48B | |
-0.87 | $115.22M | |
-6.96 | $1.04B | |
-4.30 | $196.75M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Milestone Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Milestone Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Milestone Pharmaceuticals Inc.'s PE Ratio?
How is the PE Ratio calculated for Milestone Pharmaceuticals Inc. (MIST)?
What is the highest PE Ratio for Milestone Pharmaceuticals Inc. (MIST)?
What is the 3-year average PE Ratio for Milestone Pharmaceuticals Inc. (MIST)?
What is the 5-year average PE Ratio for Milestone Pharmaceuticals Inc. (MIST)?
How does the current PE Ratio for Milestone Pharmaceuticals Inc. (MIST) compare to its historical average?